Organon & Co (OGN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Organon & Co (OGN) is Neutral.

The composite score behind that read is +0.15, weighing +0.32 of bullish evidence against -0.15 bearish.

Organon & Co last closed at $13.70, -0.15% on the session.

Against the IVW growth benchmark the position is -0.76% over the forecast window.

The read is built from 11 underlying insights — 8 bullish and 3 bearish.

Agreement across those insights is 73%.

Organon & Co has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Organon & Co in the 53rd percentile on valuation and the 83rd percentile on return on equity, where 100 is best.

Organon & Co is classified under Health Care / Pharmaceuticals, with a market capitalisation of $3.60B.

StockMap tracks Organon & Co as the 28th largest of the 142 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 61 Moderate Underperform, 57 Neutral, 19 Strong Underperform and 5 Moderate Outperform.

On that composite Organon & Co ranks 12th of 142 in the group, against a group median of -0.24.